Dr. Yuanyuan Zhang 张媛媛
Chief Physician, Associate Professor
Department of Gynecology, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis, surgery, and chemotherapy for benign and malignant gynecologic tumors, including endometrial, cervical, ovarian, fallopian tube, and gestational trophoblastic diseases. Performs laparoscopic (including single-port), hysteroscopic, and open procedures.
Dr. Zhang is Chief Physician, Associate Professor, and Master’s Supervisor at the Affiliated Cancer Hospital of Xinjiang Medical University, serving as Deputy Director of the Fifth Department of Gynecologic Surgery. Dr. Zhang earned a bachelor’s degree in clinical medicine from Xinjiang Medical University in 2005, a master’s in oncology in 2008, and a PhD in 2015. Training included a fellowship at Fudan University Shanghai Cancer Center (2017–2018). Dr. Zhang has participated in or led 10 research projects and published over 20 papers, including 5 SCI articles.
Professional roles
- Member, Chinese Medical Association Xinjiang Branch
- Youth Committee Member, Gynecologic Oncology Professional Committee, China Anti-Cancer Association
- Vice Chair, Youth Committee, Xinjiang Gynecologic Oncology Professional Committee, Chinese Medical Association
Name order: in Chinese the family name comes first (Zhang Yuanyuan). Papers usually list the name as Yuanyuan Zhang or Zhang Y.
Selected publications
15 papers on PubMed matched by name and affiliation; 3 as first or senior author since 2016. Most recent first- or senior-author papers:
- Mol Carcinog, 2026 (first author): Transcription Factor ELF3 Promotes Cervical Cancer Progression via Transcriptional Upregulation of GMPS. PubMed 42623510
- Hum Cell, 2026 (first author): GMPS promotes cervical squamous cell carcinoma cell immune evasion through USP7-mediated deubiquitination of PDL1. PubMed 42704520
- J Int Med Res, 2026 (first author): Dual-specificity phosphatase 14 inhibits the growth of cervical cancer cells by regulating the transforming growth factor-beta-activated kinase 1 and NOD-like receptor pyrin domain containing 3 inflammatory pathways. PubMed 42050913
- Asian Pac J Cancer Prev, 2015 (first author): Serum carotenoid, retinol and tocopherol concentrations and risk of cervical cancer among Chinese women. PubMed 25854393
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion